idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
idw-Abo
Medienpartner:
Wissenschaftsjahr


Share on: 
02/01/2017 13:31

EMBO Molecular Medicine appoints Philippe Sansonetti as new Chief Editor

Dr. Tilmann Kiessling EMBO Communications
EMBO - excellence in life sciences

    Heidelberg, 1 February 2017 – EMBO is pleased to announce the appointment of microbiologist Philippe Sansonetti as new Chief Editor of EMBO Molecular Medicine. Dr Sansonetti, who is the Director of the Molecular Microbial Pathogenesis Laboratory at the Institut Pasteur in Paris, takes up the post with immediate effect.

    EMBO Molecular Medicine offers those working at the interface of clinical and basic research a widely visible Open Access forum for publishing high impact research. The journal employs all the EMBO Press transparency policies, including the publication of referee comments alongside editorial and author exchanges, referee-cross commenting and pre-decision author consultation.

    Commenting on Sansonetti’s appointment, Bernd Pulverer, Head of Scientific Publications at EMBO, says: “Philippe enjoys a world-class reputation for his research in medical microbiology that bridges basic and translational research. His focus on disease and public health perfectly embodies the scope of the journal.”

    Sansonetti has been part of EMBO Molecular Medicine’s editorial team since the journal’s inception in 2009. As senior editor, he has helped to develop the publication into a premier Open Access journal for translational research. With a global readership ranging from clinicians to molecular biologists, the journal helps to translate research effectively from bench to bedside.

    In his new position as Chief Editor, Philippe Sansonetti plans to embrace the advances in molecular medicine in basic and clinical settings.

    “Molecular medicine is on an ascending limb in all medical disciplines, covering diagnostics, therapeutics and prophylaxis in fields ranging from neuroscience and cardiology to infectious diseases and cancer. Even surgery benefits from a molecular understanding of tissue healing and organ repair” states Sansonetti. “My vision is to further develop EMBO Molecular Medicine into an inclusive forum that reflects the vibrant evolution of molecular medicine on all fronts.”

    Sansonetti’s predecessor, renowned cardiovascular biologist Dr Stefanie Dimmeler, will continue to serve as Senior Editor for EMBO Molecular Medicine.

    Pulverer notes: “Stefanie’s dedication and creativity catalyzed the journal’s success so far. I am pleased that she has agreed to continue to serve as a Senior Editor, and excited to see how the combination of our editorial team’s experience and Philippe’s vision will drive the future success of EMBO Molecular Medicine.”

    INFORMATION FOR EDITORS

    Biosketch
    Microbiologist Philippe Sansonetti trained as a medical doctor at the Université Paris VI, France before moving into research. In 1989 he founded and became the director of the Insitut Pasteur’s Molecular Microbial Pathogenesis Unit. He is Professor of Microbiology and Infectious Diseases at the Collège de France. He has acted as Medical Director of the Institut Pasteur hospital, and held administrative positions at INSERM, the French Ministry of Research and Technology and the World Health Organisation.
    Sansonetti’s research focuses on the molecular pathogenesis of bacterial infections. He has contributed detailed understanding of the molecular mechanisms through which Shigella invades and kills cells, and is developing vaccine candidates against this dysentery-causing bacterium.
    His work has been recognized by numerous awards and he is an elected member of national and international organisations, including EMBO, the French Academy of Sciences, The Royal Society and the US National Academy of Sciences.

    About EMBO Molecular Medicine and EMBO Press

    EMBO Molecular Medicine is one of four leading journals published by EMBO Press. It is a peer-reviewed, online Open Access journal dedicated to a new research discipline at the interface between clinical research and basic biology. It offers those working in this area the opportunity to publish their best work in a broadly distributed and highly visible forum, thereby helping to forge new links between clinicians and molecular biologists.

    EMBO Press stands for publishing impactful, high quality and reliable research across the biosciences in its four journals, The EMBO Journal, EMBO Reports, Molecular Systems Biology and EMBO Molecular Medicine.

    EMBO Press pioneered the transparent editorial process in order to provide a rapid, fair and efficient publication process. Through developing and employing Source Data tools, EMBO Press works towards improving data transparency, reuse and discoverability. Through dedicated data integrity checks, it ensures the publication of reliable data. All submitted manuscripts are subject to scooping protection, which extends to manuscripts published on preprint servers. As a co-signatory of the San Francisco Declaration for Research Assessment, EMBO Press is an advocate for moving away from impact factors as a mechanism for research assessment.

    About EMBO

    EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.

    EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. 
For more information: www.embo.org

    Contact:

    Bernd Pulverer
    Head of Scientific Publications
    Chief Editor, The EMBO Journal
    T. + 49 6221 8891 501
    bernd.pulverer@embo.org


    More information:

    http://www.embo.org/news/press-releases/2017/embo-molecular-medicine-appoints-ph...


    Criteria of this press release:
    Journalists
    Biology
    transregional, national
    Scientific Publications
    English


    Welcome to Philippe Sansonetti as new Chief Editor. Philippe’s vision: ‘an inclusive forum reflecting the evolution of molecular medicine’


    For download

    x

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).

    Cookies optimize the use of our services. By surfing on idw-online.de you agree to the use of cookies. Data Confidentiality Statement
    Okay